XML 21 R6.htm IDEA: XBRL DOCUMENT v3.23.2
CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS’ EQUITY - USD ($)
$ in Thousands
Total
Cumulative Effect, Period Of Adoption, Adjustment
Various Stock Compensation Plans And Agreements
Stock Repurchase Plan
Common Stock
Common Stock
Various Stock Compensation Plans And Agreements
Common Stock
Stock Repurchase Plan
Common Stock and Additional Paid-in Capital
Retained Earnings
Retained Earnings
Cumulative Effect, Period Of Adoption, Adjustment
Treasury Stock
Treasury Stock
Various Stock Compensation Plans And Agreements
Treasury Stock
Stock Repurchase Plan
AOCI, Net of Tax
Beginning balance (in shares) at Dec. 31, 2021         141,907,954                  
Beginning balance at Dec. 31, 2021 $ 5,837,218             $ 1,893,725 $ 4,683,659   $ (649,785)     $ (90,381)
Increase (Decrease) in Stockholders' Equity                            
Net income 495,981               495,981          
Other comprehensive loss (510,267)                         (510,267)
Issuance of common stock pursuant to various stock compensation plans and agreements (in shares)         639,847                  
Issuance of common stock pursuant to various stock compensation plans and agreements 20,507             20,507            
Repurchase of common stock pursuant to the Stock Repurchase Program/various stock compensation plans and agreements (in shares)           (244,895) (1,385,517)              
Repurchase of common stock pursuant to the Stock Repurchase Program/various stock compensation plans and agreements     $ (18,977) $ (99,990)               $ (18,977)    
Cash dividends on common stock (114,990)               (114,990)          
Ending balance (in shares) at Jun. 30, 2022         140,917,389                  
Ending balance at Jun. 30, 2022 5,609,482             1,914,232 5,064,650   (768,752)     (600,648)
Beginning balance (in shares) at Mar. 31, 2022         142,256,520                  
Beginning balance at Mar. 31, 2022 5,703,456             1,903,042 4,863,721   (668,382)     (394,925)
Increase (Decrease) in Stockholders' Equity                            
Net income 258,329               258,329          
Other comprehensive loss (205,723)                         (205,723)
Issuance of common stock pursuant to various stock compensation plans and agreements (in shares)         51,733                  
Issuance of common stock pursuant to various stock compensation plans and agreements 11,190             11,190            
Repurchase of common stock pursuant to the Stock Repurchase Program/various stock compensation plans and agreements (in shares)           (5,347) (1,385,517)              
Repurchase of common stock pursuant to the Stock Repurchase Program/various stock compensation plans and agreements     (380) $ (99,990)               (380) $ (99,990)  
Cash dividends on common stock (57,400)               (57,400)          
Ending balance (in shares) at Jun. 30, 2022         140,917,389                  
Ending balance at Jun. 30, 2022 5,609,482             1,914,232 5,064,650   (768,752)     (600,648)
Beginning balance (in shares) at Dec. 31, 2022         140,947,846                  
Beginning balance at Dec. 31, 2022 5,984,612             1,936,557 5,582,546   (768,862)     (765,629)
Beginning balance (Accounting Standards Update 2022-02) at Dec. 31, 2022 [1]   $ (4,262)               $ (4,262)        
Increase (Decrease) in Stockholders' Equity                            
Net income 634,470               634,470          
Other comprehensive loss (16,303)                         (16,303)
Issuance of common stock pursuant to various stock compensation plans and agreements (in shares)         851,819                  
Issuance of common stock pursuant to various stock compensation plans and agreements 23,227             23,227            
Repurchase of common stock pursuant to the Stock Repurchase Program/various stock compensation plans and agreements (in shares)           (315,997)                
Repurchase of common stock pursuant to the Stock Repurchase Program/various stock compensation plans and agreements     (23,028)                 (23,028)    
Cash dividends on common stock (137,019)               (137,019)          
Ending balance (in shares) at Jun. 30, 2023         141,483,668                  
Ending balance at Jun. 30, 2023 6,461,697             1,959,784 6,075,735   (791,890)     (781,932)
Beginning balance (in shares) at Mar. 31, 2023         141,395,800                  
Beginning balance at Mar. 31, 2023 6,309,331             1,947,687 5,832,291   (790,653)     (679,994)
Increase (Decrease) in Stockholders' Equity                            
Net income 312,031               312,031          
Other comprehensive loss (101,938)                         (101,938)
Issuance of common stock pursuant to various stock compensation plans and agreements (in shares)         111,097                  
Issuance of common stock pursuant to various stock compensation plans and agreements 12,097             12,097            
Repurchase of common stock pursuant to the Stock Repurchase Program/various stock compensation plans and agreements (in shares)           (23,229)                
Repurchase of common stock pursuant to the Stock Repurchase Program/various stock compensation plans and agreements     $ (1,237)                 $ (1,237)    
Cash dividends on common stock (68,587)               (68,587)          
Ending balance (in shares) at Jun. 30, 2023         141,483,668                  
Ending balance at Jun. 30, 2023 $ 6,461,697             $ 1,959,784 $ 6,075,735   $ (791,890)     $ (781,932)
[1] Represents the change in the Company’s allowance for loan losses as a result of the adoption of Accounting Standards Update (“ASU”) 2022-02, Financial Instruments - Credit Losses (Topic 326): Troubled Debt Restructurings and the Vintage Disclosures on January 1, 2023. Refer to Note 2 — Current Accounting Developments and Summary of Significant Accounting Policies in this Form 10-Q for additional information.